2005
DOI: 10.4103/0378-6323.16619
|View full text |Cite
|
Sign up to set email alerts
|

An open randomized comparative study of oral itraconazole pulse and terbinafine pulse in the treatment of onychomycosis

Abstract: Both oral itraconazole and terbinafine are effective in the treatment of onychomycosis when administered in the pulse dosage form. Terbinafine is more cost effective while itraconazole has a broader spectrum of antimycotic activity.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
17
0

Year Published

2007
2007
2019
2019

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(18 citation statements)
references
References 16 publications
1
17
0
Order By: Relevance
“…In the treatment of distal and lateral subungual onychomycosis restricted to dermatophytes, no appreciable difference was observed between itraconazole (400 mg/day one week "on" three weeks "off ") and terbinafi ne (mycological cure rates: 75%-90% vs 76%-87%, clinical cure rates 53%-82% vs 50%-79%). [135][136][137][138] Not surprisingly, itraconazole demonstrated superior cure rates among the non-dermatophyte moulds (62% vs 44%) and Candida species (92% vs 40%). 138 These studies are contradicted by a large multi-national trial wherein mycological cure rates at 18 months were significantly greater with terbinafine (76%-80%) than observed with pulse-dose itraconazole (38%-49%).…”
Section: Onychomycosismentioning
confidence: 99%
See 1 more Smart Citation
“…In the treatment of distal and lateral subungual onychomycosis restricted to dermatophytes, no appreciable difference was observed between itraconazole (400 mg/day one week "on" three weeks "off ") and terbinafi ne (mycological cure rates: 75%-90% vs 76%-87%, clinical cure rates 53%-82% vs 50%-79%). [135][136][137][138] Not surprisingly, itraconazole demonstrated superior cure rates among the non-dermatophyte moulds (62% vs 44%) and Candida species (92% vs 40%). 138 These studies are contradicted by a large multi-national trial wherein mycological cure rates at 18 months were significantly greater with terbinafine (76%-80%) than observed with pulse-dose itraconazole (38%-49%).…”
Section: Onychomycosismentioning
confidence: 99%
“…[135][136][137][138] Not surprisingly, itraconazole demonstrated superior cure rates among the non-dermatophyte moulds (62% vs 44%) and Candida species (92% vs 40%). 138 These studies are contradicted by a large multi-national trial wherein mycological cure rates at 18 months were significantly greater with terbinafine (76%-80%) than observed with pulse-dose itraconazole (38%-49%). 139 In selected subpopulations, complete cure rates observed after 4 years remained superior in the terbinafi ne arm (24%-78%) compared with those receiving itraconazole (24%-28%) as did mycological cure (46% vs 13%).…”
Section: Onychomycosismentioning
confidence: 99%
“…Mishra et al (26) conducted a study of oral itraconazole and terbinafine pulse therapy for onychomycosis. They found an approximately 50% cure rate from both drugs 4 months after complete treatment, although fungal cultures in all patients were still positive 3 months after complete treatment.…”
Section: Discussionmentioning
confidence: 99%
“…11 Mishra et al noted clinical cure rate of 82% and mycological cure rate of 90% with itraconazole pulse therapy in dermatophyte caused toenail onychomycosis. 12 Gupta et al attained mycological cure by 88.2% and clinical cure by 52.9% in patients of toenail onychomycosis caused by dermatophytes treated with itraconazole pulse therapy. 13 They also observed itraconazole pulse therapy effective and safe in people with diabetes.…”
Section: Discussionmentioning
confidence: 99%